Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment
US5864016A · kind A · utility
12Cited by
20References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 1994 |
| Grant date | Jan 26, 1999 |
| Priority date | — |
| Expiry date | Jul 28, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2/0023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A blood product, exclusive of albumin, inactivated relative to infectious agents, the blood product conforming to a total virus reduction factor of at least 40, having a biological acitity of at least 50%, based on its activity prior to effecting inactivation of the infectious agents, the blood product being producible from conventional blood products and being virus-safe.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.